home > research channels > sectors > pharma


Latest News
31-Mar-2017 Indian Cos Vie for Novartis' Respiratory Brands
22-Mar-2017 US Ban on Divi's Labs may Dent Profits by Up to 25%
20-Mar-2017 Daiichi's Ranbaxy Profits Outweigh Losses: Singhs
15-Mar-2017 Sun's Mohali Facility Out of FDA Cloud
  more...
Latest Reports
Jun-17 Enough Headroom To Grow For Indian Generic Companies - Nirmal Bang  
Jun-17 US drug pricing task force spells bad news for generic companies - Emkay Research  
Jun-17 US price pressure to dent near term growth - ICICI direct.com  
Jun-17 Base business pressures to remain - IIFL  
  more...

Quarterly Summary (March Quarter)
Desc Current Previous Per.Chg
Sales 33255.3 33142.3 0.3
Otherincome 1188.2 1201.6 -1.1
Expense 28408.5 27763.7 2.3
RawMaterial 10412.2 9749.1 6.8
StaffCost 4951.9 4642.4 6.7
ExciseDuty 173.6 51.4 237.6
OtherExp 10238.3 9552.8 7.2
Interest 718.4 939.1 -23.5
GrossProfit 6113.5 6834.6 -10.6
Depreciation 1527.4 1420.1 7.6
Tax 396.5 1165.6 -66.0
NetProfit 3881.0 4041.8 -4.0
Total.Comp 163 -- --
Source: ETIG Database

Sectoral Companies As on 23 Jun 2017
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 130509.92
Cadila Healt 53754.49
Piramal Entp 48669.45
Lupin 47918.59
Dr.Reddy's 43807.37
Cipla 43514.09
Aurobindo Ph 39334.40
Alkem Labora 21819.67
GlaxoSmith.P 20876.43
Torrent Phar 19927.35
Biocon 19782.00
Glenmark Pha 17706.64
Natco Pharma 16950.68
  click here for the complete list